Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Epidermal barrier repair is the process by which the skin restores its outer protective barrier—primarily the stratum corneum—to prevent water loss, block invading pathogens and chemicals, and maintain healthy skin homeostasis. The process is carried out by coordinated interactions among keratinocytes, immune cells, structural proteins (filaggrin, loricrin, involucrin), lipids (ceramides, cholesterol, free fatty acids), cell–cell junctions (tight junctions, desmosomes), and multiple signaling pathways. Disruption of this process underlies several inflammatory and infectious skin disorders. Therapeutic interventions are generally aimed at supporting or accelerating physiological repair rather than targeting a single defined molecule or receptor[1][2][3][4].
Promote lipid synthesis (ceramides, cholesterol, FFA) Suppress inflammation Enhance cell proliferation/differentiation of keratinocytes Support re-epithelialization Antimicrobial peptide induction
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Epidermal barrier repair.